NCT00322075View on ClinicalTrials.gov

LANCGMS - Lantus Continuous Glucose Monitoring Subcutaneous

PHASE4CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

November 30, 2006

Conditions

Diabetes Mellitus

Interventions

DRUG

insulin glargine

Trial Locations (1)

Unknown

Sanofi-Aventis, Prague

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00322075 - LANCGMS - Lantus Continuous Glucose Monitoring Subcutaneous | Biotech Hunter | Biotech Hunter